Synthetic Histopathological Images Generation with Artificial Intelligence to Accelerate Research and Improve Clinical Outcomes in Hematology
Gianluca Asti(IRCCS Humanitas Research Hospital), Matteo Giovanni Della Porta(Humanitas University), Lin-Pierre Zhao(Assistance Publique – Hôpitaux de Paris), Pierre Fenaux(Hôpital Avicenne), Lorenzo Dall’Olio, Victor Savevski(Humanitas University), Alessia Campagna(Humanitas University), Elisabetta Sauta(IRCCS Humanitas Research Hospital), Matteo Zampini(Humanitas University), Gastone Castellani(University of Bologna), Gianluca Carlini(Institute of Neurological Sciences), Anne Sophie Kubasch(Leukemia and Lymphoma Society), Claudia Sala, Daniele Dall’Olio, Torsten Haferlach(Munich Leukemia Laboratory (Germany)), Cristina Astrid Tentori(IRCCS Humanitas Research Hospital), Shahram Kordasti(Guy's Hospital), Gabriele Todisco(Humanitas University), María Díez‐Campelo(Complejo Hospitalario de Salamanca), Amer M. Zeidan(Yale Cancer Center), Nico Curti(Institute of Neurological Sciences), Nicolas Riccardo Derus(University of Bologna), Marta Ubezio(Humanitas University), Maria Chiara Grondelli(Istituti di Ricovero e Cura a Carattere Scientifico), Uwe Platzbecker(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Pierandrea Morandini(IRCCS Humanitas Research Hospital), Giulia Maggioni(Humanitas University), Luca Lanino(Humanitas University), Valeria Santini(University of Florence), Armando Santoro(IRCCS Humanitas Research Hospital), Saverio D’Amico(Humanitas University), Antonio Russo(Humanitas University), Marilena Bicchieri(Istituti di Ricovero e Cura a Carattere Scientifico)
Cited by 2
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k